Stocks and Investing Stocks and Investing
Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021
Thu, December 2, 2021
Wed, December 1, 2021

Graig Suvannavejh Maintained (TGTX) at Strong Sell with Decreased Target to $13 on, Dec 1st, 2021


Published on 2024-10-27 18:49:28 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Sell with Decreased Target from $26 to $13 on, Dec 1st, 2021.

Graig, nor any peers, have made any analyst calls on TGTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30